EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe

Daniel J Rohrbach, Kevin A Carter, Dandan Luo, Shuai Shao, Semra Aygun-Sunar, Jonathan F Lovell iD, Ulas Sunar iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Daniel J Rohrbach und 6 weiteren Autor:innen. Beteiligte Einrichtung: Agilent Technologies, Winooski, Vermont, VT 05404, USA. Hauptthemen laut MEDLINE: Doxorubicin, Endoscopy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH/NCI R01.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liposomal doxorubicin (Dox), a treatment option for recurrent ovarian cancer, often suffers from suboptimal biodistribution and efficacy, which might be addressed with precision drug delivery systems. Here, we introduce a catheter-based endoscopic probe designed for multispectral, quantitative monitoring of light-triggered drug release. This tool utilizes red-light photosensitive porphyrin−phospholipid (PoP), which is encapsulated in liposome bilayers to enhance targeted drug delivery. By integrating diffuse reflectance and fluorescence spectroscopy, our approach not only corrects for the effects of tissue optical properties but also ensures accurate drug delivery to deep-seated tumors. Preliminary results validate the probe’s effectiveness in controlled settings, highlighting its potential for future clinical adaptation. This study sets the stage for in vivo applications, enabling the exploration of next-generation treatment paradigms for the management of cancer that involve optimizing chemotherapy administration for precision and control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinEndoscopyHumansFemaleAnimalsPolyethylene GlycolsLightDrug LiberationMiceKineticsLiposomesDrug Delivery SystemsOvarian NeoplasmsSpectrometry, FluorescenceAntibiotics, AntineoplasticPorphyrinsCell Line, Tumor

Stichwörter der Autor:innen

diffuse fluorescence spectroscopydiffuse reflectance spectroscopydoxorubicin drug concentrationendoscopic probelight-triggered releasephotodynamic therapyporphyrins

Substanzen

Doxorubicinliposomal doxorubicinPolyethylene GlycolsLiposomesAntibiotics, AntineoplasticPorphyrins

Autor:innen und Institutionen

  • Agilent Technologies, Winooski, Vermont, VT 05404, USA.
  • Department of Biomedical Engineering, University at Buffalo, Buffalo, NY 14260, USA.
  • Department of Biomedical, Engineering, Stony Brook University, Stony Brook, NY 11794, USA.

ORCID-Profile: Jonathan F Lovell, Ulas Sunar

Förderung

  • NCI NIH HHS
  • NIH/NCI R01

Zitieren

APA

Rohrbach, D. J., Carter, K. A., Luo, D., Shao, S., Aygun-Sunar, S., Lovell, J. F., & Sunar, U. (2025). Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031212

Vancouver

Rohrbach DJ, Carter KA, Luo D, Shao S, Aygun-Sunar S, Lovell JF, et al. Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031212

BibTeX
@article{Rohrbach2025,
  author = {Rohrbach, Daniel J and Carter, Kevin A and Luo, Dandan and Shao, Shuai and Aygun-Sunar, Semra and Lovell, Jonathan F and Sunar, Ulas},
  title = {Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031212}
}
Kostenlos starten →